Difficulty: Medium
Average Score: 72%
Practice
what is the main reason for giving a progestational medication to perimenopausal women who use estrogen?
Correct answer
D
Rationale
The main reason for giving a progestational medication to perimenopausal women who use estrogen is to decrease the risk of endometrial hyperplasia.
Explanation:
- Estrogen therapy alone can increase the risk of endometrial hyperplasia, which is a precursor to endometrial cancer. Progestational medications help counteract this by opposing the estrogen-driven proliferation of the endometrial lining, reducing the risk of hyperplasia and cancer development.
Why other options are wrong:
- A) Preventing hot flashes: Progestational medications are not primarily used for this purpose in perimenopausal women. Hormone replacement therapy with estrogen is more commonly used to alleviate hot flashes.
- B) Preventing osteoporosis: While estrogen can help prevent osteoporosis, progestational medications are not the main agents for addressing bone health in perimenopausal women.
- C) Promoting growth of uterine lining: This is the opposite of what progestational medications do. They actually counteract the growth-promoting effects of estrogen on the uterine lining.
Educational context:
Understanding the rationale behind using a combination of estrogen and progestational medications in perimenopausal women is crucial for healthcare providers involved in managing menopausal symptoms and hormone replacement therapy. This knowledge ensures safe and effective treatment regimens tailored to individual patient needs, taking into account both symptom management and potential risks associated with hormone therapy.
Explanation:
- Estrogen therapy alone can increase the risk of endometrial hyperplasia, which is a precursor to endometrial cancer. Progestational medications help counteract this by opposing the estrogen-driven proliferation of the endometrial lining, reducing the risk of hyperplasia and cancer development.
Why other options are wrong:
- A) Preventing hot flashes: Progestational medications are not primarily used for this purpose in perimenopausal women. Hormone replacement therapy with estrogen is more commonly used to alleviate hot flashes.
- B) Preventing osteoporosis: While estrogen can help prevent osteoporosis, progestational medications are not the main agents for addressing bone health in perimenopausal women.
- C) Promoting growth of uterine lining: This is the opposite of what progestational medications do. They actually counteract the growth-promoting effects of estrogen on the uterine lining.
Educational context:
Understanding the rationale behind using a combination of estrogen and progestational medications in perimenopausal women is crucial for healthcare providers involved in managing menopausal symptoms and hormone replacement therapy. This knowledge ensures safe and effective treatment regimens tailored to individual patient needs, taking into account both symptom management and potential risks associated with hormone therapy.